Search for information about a product,
therapeutic area or event

Search

Media, investors, advocacy organizations and others, please contact us here.

Medical Information FSGS

FILSPARI (sparsentan) – Effect on Proteinuria in Focal Segmental Glomerulosclerosis

Learn more
Medical Information FSGS

FILSPARI (sparsentan) – Pediatric Patients in Sparsentan FSGS Studies

Learn more
Medical Information FSGS

FILSPARI (sparsentan) – Acute Kidney Injury

Learn more
Medical Information FSGS

FILSPARI (sparsentan) – Impact on Pregnancy, Lactation, and Fertility

Learn more
Medical Information FSGS

FILSPARI (sparsentan) – DUPLEX (Phase 3 Study): Study Design & Topline Results

Learn more
Medical Information FSGS

FILSPARI (sparsentan) Dual Receptor Antagonism in Renal Pathophysiology and Reduction of Proteinuria

Learn more
Medical Information FSGS

FILSPARI (sparsentan) – Decreases in Hemoglobin

Learn more
Medical Information FSGS

FILSPARI (sparsentan) – Mechanism of Action and Pharmacology

Learn more
Medical Information FSGS

FILSPARI (sparsentan): Elevated Liver Transaminases and Hepatic Safety Results

Learn more
Medical Information FSGS

FILSPARI (sparsentan) – Concomitant Medications Included in Clinical Trials

Learn more
Medical Information FSGS

FILSPARI (sparsentan) – Changes in Blood Pressure and Hypotensive Events

Learn more
Medical Information FSGS

FILSPARI (sparsentan) – Safety and Efficacy in Focal Segmental Glomerulosclerosis (FSGS)

Learn more
Medical Information FSGS

FILSPARI (sparsentan) – Use with Diuretics in IgA Nephropathy and FSGS

Learn more